Preclinical models of Parkinson's disease (PD) have been developed using intracerebroventricular (i.c.v.) injection of 6-hydroxydopamine (6-OHDA) to induce neurodegeneration and motor dysfunction.

The California Department of Insurance has been under pressure to stabilize the market, introducing new rules that allow ...

One afternoon in 2022, when it became clear that the Tennessee Department of Correction had violated or otherwise ignored ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) ...

The consortium expects phase 4 to average 21,000 barrels of oil equivalent a day. The development consists of three oil ...

Gerry Weber, the German fashion supplier, has filed for insolvency again. This is the third insolvency in six years, due to ...

Profits and losses for petrelintide and the petrelintide/CT-388 combination will be shared on a 50:50 basis in the U.S. and Europe, while Zealand will be eligible to receive tiered double-digit ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...

When patients die, CEOs rarely get charged. Why it’s different in the Oxford Center case. The state’s pursuit of murder ...

The global nuclear medical equipment market is poised for steady growth, expanding at a CAGR of 4.1% from 2022 to 2032. Market projections indicate that the sector will increase from USD 2.3 billion ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...